Alnylam Pharmace. buy William Blair
Summary
This prediction ended on 26.07.24 with a price of €219.00. The prediction had a final performance of 25.14%. William_Blair has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. William_Blair has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Alnylam Pharmace. | -1.219% | -1.219% | 43.566% |
iShares Core DAX® | -1.958% | 4.037% | 23.702% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% |
Comments by William_Blair for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.